AstraZeneca to buy EsoBiotec for up to $1 billion
EsoBiotec’s platform has the potential to transform cell therapy, according to AstraZeneca, by empowering the immune system to attack cancers
All posts by Bloomberg
Read More »
Bloomberg
13:19
Trump says he’ll impose both reciprocal and sectoral tariffs
‘They charge us and we charge them and then in addition to that on autos on steel on aluminium we
Bloomberg
02:22
Baidu releases reasoning AI model to take on DeepSeek
The Ernie X1 model by China’s internet search leader works similarly to DeepSeek R1...
Bloomberg
00:21
China maps out plan to raise incomes and boost consumption
Other measures include stabilizing the stock and real estate markets, and offering incentives to raise the country’s birth rate...
Bloomberg
11:20
While Musk tries to save US govt $1 trillion, China is struggling to spend enough cash
China is grappling with underspending its budget due to local officials' concerns over investment returns amidst efforts to address a
Bloomberg
07:20
Trump says four bidders in play for TikTok deal soon
ByteDance Ltd.’s TikTok faces a deadline of April 5 to strike a deal for its US operations — or be
Bloomberg
07:20
Metals decline on weak China data and US tariff uncertainty
Copper extended its slide from a four-month high, dropping 0.3% to $9,588 a ton by 10:23 a.m. Shanghai time on
Bloomberg
14:19
Disney cuts 200 jobs across units
Walt Disney Co. cuts 200 jobs at ABC and entertainment TV networks to boost efficiencies and reduce costs.
Bloomberg
19:19
Modi says global turmoil is time for Indian firms to invest more
The prime minister asked manufacturers and exporters to “take big steps” to not only benefit from the changing global order
Bloomberg
18:26
Tata Capital eyes $11 billion valuation for India IPO
Tata Group plans to list Tata Capital, targeting an $11 billion valuation in India’s biggest IPO of 2024. The offering
